Cordis, a global leader in interventional cardiovascular technology, today announced the groundbreaking results from the ...
The DCB is meant to address long-term stent-related complications and avoid adding yet another metal layer in ISR.
A major randomized trial has found that percutaneous coronary intervention is now more cost-effective than bypass grafting over 5 years of follow-up.
Orchestra BioMed’s Virtue® Sirolimus AngioInfusionTM Balloon (“Virtue SAB”) is the first non-coated drug-eluting balloon system designed to deliver a large liquid dose of proprietary extended-release ...
18hon MSN
Susan Lucci stuns in tiny red lace dress as she pays tribute to 'the man who saved my life'
All My Children star Susan Lucci turned heads in a tiny red dress as she posed alongside the doctor who saved her life in ...
Medtronic plc , a global leader in healthcare technology, today announced new, long-term results from its final report of the SPYRAL HTN-ON MED randomized clinical trial, showing that patients treated ...
Guardant Health, Inc. , a leading precision oncology company, today announced the company and its research collaborators will present data showing the critical role of blood-based testing in ...
“Cutting balloon angioplasty is a reasonable and less costly option when compared with intravascular lithotripsy for the ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback